These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4476404)

  • 1. [Proceedings: Clinical application of CB-154].
    Seki K; Seki M; Okumura Y; Itabashi M; Chimoto H
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):290. PubMed ID: 4476404
    [No Abstract]   [Full Text] [Related]  

  • 2. [Proceedings: Endocrinological observation and treatment of lactation disorders with CB-154].
    Sato Y; Ueda G; Hayakawa K; Yoshinare S; Yamazaki M
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):304. PubMed ID: 4476417
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].
    Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Michel E; Nevinny-Stickel J
    Geburtshilfe Frauenheilkd; 1977 Jun; 37(6):500-8. PubMed ID: 328335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactation-inhibiting and prolactin-lowering effect of lisuride and transdihydrolisuride. A comparative study.
    Vĕtr M; Konecný V
    Acta Univ Palacki Olomuc Fac Med; 1988; 120():295-300. PubMed ID: 2977904
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hyperprolactinaemic endocrinopathy in gynaecological practice (author's transl)].
    Alexander H; Herter U; Müller R; Brockmann J
    Zentralbl Gynakol; 1980; 102(6):346-52. PubMed ID: 7193390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Letter: Inhibition of lactation by an antiprolactin substance, CB 154].
    Morin P; Engelmann P; Coustenoble G; Lebrun ; Gueris D
    Nouv Presse Med; 1975 Nov; 4(39):2811-2. PubMed ID: 1105425
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolactin response to TRH during inhibition of puerperal lactation with ergolinic drugs.
    Crosignani PG; Lombroso GC; Trojsi L; Caccamo A; Reschini E; Peracchi M
    Horm Metab Res; 1977 Mar; 9(2):163-4. PubMed ID: 405303
    [No Abstract]   [Full Text] [Related]  

  • 8. [Our experience in the inhibition of lactation (Controlled clinical study with bromocriptine, methergoline and pyridoxine)].
    Vecchione A; Baccolo M
    Riv Ital Ginecol; 1980; 59(2-3):311-9. PubMed ID: 7020052
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of methergoline and of a synthetic estrogen on plasmatic prolactin levels and on postpartum lactation].
    Boemi P; Pace G; Cianci A; Pellicciotta G; Palumbo G
    Minerva Ginecol; 1980 Mar; 32(3):135-42. PubMed ID: 6445525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ergolines as potential prolactin and mammary tumor inhibitors.
    Cassady JM; Floss HG
    Lloydia; 1977; 40(1):90-106. PubMed ID: 327183
    [No Abstract]   [Full Text] [Related]  

  • 11. The treatment of puerperal lactation with bromocriptine.
    Cooke I; Foley M; Lenton E; Preston E; Millar D; Jenkins A; Obiekwe B; McNeilly A; Parsons J; Kennedy G
    Postgrad Med J; 1976; 52suppl 1():75-80. PubMed ID: 959129
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of methergoline in inhibition of puerperal lactation].
    Iannotta F; Berra G
    Minerva Ginecol; 1979 May; 31(5):399-404. PubMed ID: 572517
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppression of puerperal lactation by metergoline.
    Crosignani PG; Lombroso GC; Caccamo A; Reschini E; Peracchi M
    Obstet Gynecol; 1978 Jan; 51(1):113-5. PubMed ID: 619329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine and clinical results in administering lisuride for inhibiting lactation.
    Zanagnolo VL; Pollini F; Falsetti L; Gastaldi A
    Acta Eur Fertil; 1987; 18(1):21-4. PubMed ID: 3115024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Lisuride on serum prolactin levels during puerperium.
    Venturini PL; Maganza C; Massimilla A; Campanella P; Rossato P; Ragni N; De Cecco L
    Acta Eur Fertil; 1979 Jun; 10(2):51-5. PubMed ID: 545976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in serum prolactin, FSH, LH and E2 levels in breast-feeding women with amenorrhea].
    Zhao M
    Zhonghua Fu Chan Ke Za Zhi; 1983 Jul; 18(3):130-3. PubMed ID: 6418474
    [No Abstract]   [Full Text] [Related]  

  • 17. Metergoline as a lactation inhibitor.
    Caballero A; Palomo A; Molina CE; Albarrán FJ; Caballero A; Mena P
    J Reprod Med; 1982 Apr; 27(4):202-6. PubMed ID: 7097670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperprolactinemic amenorrhea. Clinical relevance, endocrine features, therapy (author's transl)].
    Rjosk HK; Werder K; Fahlbusch R
    Geburtshilfe Frauenheilkd; 1976 Jul; 36(7):575-87. PubMed ID: 986336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical experiences with the prolactin-inhibiting serotonin antagonist metergoline].
    Schneider WH; Huber H; Spona J
    Wien Klin Wochenschr; 1983 Jun; 95(13):452-5. PubMed ID: 6636776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of lactation using a synthetic antiprolactin].
    Kaufmann E
    Gynakol Rundsch; 1976; 16(2):107-12. PubMed ID: 989754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.